Page last updated: 2024-10-25

clenbuterol and Non-ST Elevated Myocardial Infarction

clenbuterol has been researched along with Non-ST Elevated Myocardial Infarction in 1 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Non-ST Elevated Myocardial Infarction: A myocardial infarction that does not produce elevations in the ST segments of the ELECTROCARDIOGRAM. ST segment elevation of the ECG is often used in determining the treatment protocol (see also ST Elevation Myocardial Infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quinley, KE1
Chen, HY1
Yang, HS1
Lynch, KL1
Olson, KR1

Reviews

1 review available for clenbuterol and Non-ST Elevated Myocardial Infarction

ArticleYear
Clenbuterol causing non-ST-segment elevation myocardial infarction in a teenage female desiring to lose weight: case and brief literature review.
    The American journal of emergency medicine, 2016, Volume: 34, Issue:8

    Topics: Adolescent; Adrenergic beta-Agonists; Anti-Obesity Agents; Clenbuterol; Female; Humans; Non-ST Eleva

2016